Literature DB >> 29657460

A quality improvement project decreases incidence of pulmonary embolism following arthroplasty.

Iyad Eid1,2, Dane Moran3,4, Lynn Morrison1, Eyad HajHussein1, Hanna Hill1, Rasha Ansari1, Tammy Williams1, Mojieb Manzary1.   

Abstract

OBJECTIVE: To develop a quality improvement initiative to reduce the incidence of pulmonary embolism (PE) following elective lower extremity joint replacement surgery.
METHODS: 866 Patients undergoing a total knee or total or partial hip replacement surgery at a from 2014 to 2016 were included in this prospective pre-post interventional study.
RESULTS: There were 13 PE's before the intervention and 2 after the intervention. The incidence of PE was significantly higher prior to the intervention (2.8% vs. 0.7%; p = 0.044).
CONCLUSIONS: Our results suggest that our bundle of interventions was successfully implemented and helped to reduce the incidence of pulmonary embolism following surgery.

Entities:  

Keywords:  Arthroplasty; DVT, deep vein thrombosis; PACY, post-anesthesia care unit; PE, pulmonary embolism; Pulmonary embolism; Quality improvement; Replacement; SCD, sequential compression device; TED, thromboembolism deterrent; VTE, venous thromboembolism

Year:  2018        PMID: 29657460      PMCID: PMC5895891          DOI: 10.1016/j.jor.2018.01.009

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  18 in total

1.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline.

Authors:  Jennifer Hill; Tom Treasure
Journal:  Heart       Date:  2010-06       Impact factor: 5.994

3.  American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.

Authors:  Norman A Johanson; Paul F Lachiewicz; Jay R Lieberman; Paul A Lotke; Javad Parvizi; Vincent Pellegrini; Theodore A Stringer; Paul Tornetta; Robert H Haralson; William C Watters
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

4.  Virchow and his triad: a question of attribution.

Authors:  Catherine N Bagot; Roopen Arya
Journal:  Br J Haematol       Date:  2008-09-06       Impact factor: 6.998

5.  Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty.

Authors:  Paul F Lachiewicz
Journal:  Instr Course Lect       Date:  2011

Review 6.  Risk assessment as a guide to thrombosis prophylaxis.

Authors:  Joseph A Caprini
Journal:  Curr Opin Pulm Med       Date:  2010-09       Impact factor: 3.155

Review 7.  Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.

Authors:  Jean-Marie Januel; Guanmin Chen; Christiane Ruffieux; Hude Quan; James D Douketis; Mark A Crowther; Cyrille Colin; William A Ghali; Bernard Burnand
Journal:  JAMA       Date:  2012-01-18       Impact factor: 56.272

Review 8.  Duration of venous thromboembolism prophylaxis after surgery.

Authors:  Clive Kearon
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

Review 9.  Venous thromboembolism: epidemiology and magnitude of the problem.

Authors:  Samuel Z Goldhaber
Journal:  Best Pract Res Clin Haematol       Date:  2012-08-09       Impact factor: 3.020

10.  Thromboprophylaxis use in medical and surgical inpatients and the impact of an electronic risk assessment tool as part of a multi-factorial intervention. A report on behalf of the elVis study investigators.

Authors:  Edward Janus; Anmol Bassi; David Jackson; Harshal Nandurkar; Mark Yates
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.